Deerfield Management Company L.P. Series C Takes $166,000 Position in Teladoc Health, Inc. (NYSE:TDOC)

Deerfield Management Company L.P. Series C acquired a new position in Teladoc Health, Inc. (NYSE:TDOC) during the second quarter, HoldingsChannel.com reports. The institutional investor acquired 16,965 shares of the health services provider’s stock, valued at approximately $166,000.

A number of other large investors have also modified their holdings of the company. ICA Group Wealth Management LLC bought a new position in Teladoc Health in the 4th quarter worth about $28,000. Signaturefd LLC grew its holdings in Teladoc Health by 148.7% in the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after buying an additional 1,715 shares in the last quarter. International Assets Investment Management LLC acquired a new stake in Teladoc Health in the 2nd quarter valued at approximately $29,000. Doheny Asset Management CA bought a new stake in Teladoc Health during the 2nd quarter valued at $46,000. Finally, SageView Advisory Group LLC acquired a new position in Teladoc Health during the 1st quarter worth $48,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Price Performance

NYSE TDOC opened at $8.46 on Friday. The company has a current ratio of 1.66, a quick ratio of 1.62 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 1 year low of $6.76 and a 1 year high of $22.54. The company has a market cap of $1.43 billion, a PE ratio of -6.00 and a beta of 0.90. The stock’s 50-day moving average price is $7.93 and its two-hundred day moving average price is $10.65.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.36) by $0.08. Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%. The business had revenue of $642.44 million for the quarter, compared to analyst estimates of $649.34 million. On average, analysts predict that Teladoc Health, Inc. will post -1.18 EPS for the current year.

Insider Activity

In related news, insider Vidya Raman-Tangella sold 3,857 shares of the stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $31,395.98. Following the completion of the sale, the insider now directly owns 33,667 shares of the company’s stock, valued at approximately $274,049.38. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, insider Vidya Raman-Tangella sold 3,857 shares of the business’s stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $8.14, for a total transaction of $31,395.98. Following the transaction, the insider now directly owns 33,667 shares of the company’s stock, valued at $274,049.38. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CMO Stephany Verstraete sold 15,000 shares of the stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $7.60, for a total transaction of $114,000.00. Following the completion of the sale, the chief marketing officer now owns 45,158 shares of the company’s stock, valued at approximately $343,200.80. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 57,819 shares of company stock worth $442,204. 0.95% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts have recently commented on TDOC shares. JPMorgan Chase & Co. lowered their price target on Teladoc Health from $16.00 to $9.00 and set a “neutral” rating on the stock in a report on Monday, August 26th. TD Cowen lowered their target price on shares of Teladoc Health from $15.00 to $9.00 and set a “hold” rating on the stock in a research note on Thursday, August 1st. Evercore ISI dropped their price target on shares of Teladoc Health from $14.00 to $10.00 and set an “in-line” rating on the stock in a research report on Tuesday, July 9th. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a report on Thursday, August 1st. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a research note on Friday, August 2nd. Fifteen research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $12.31.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.